Management of lung cancer
- Adult bronchopulmonary cancers: non-small cell and small cell carcinomas
- Pleural tumours: mesothelioma and others
- Mediastinal tumours: thymoma and others
- Pleuropulmonary metastases requiring local treatment (committee-coordinated management depending on the primary tumour site)
The International Thoracic Cancer Centre
Gustave Roussy has joined forces with the Marie-Lannelongue Hospital and the Paris Saint-Joseph Hospital, also internationally acclaimed stakeholders, pooling their complementary skills to create the International Thoracic Cancer Centre (CICT). This healthcare collaboration offers a comprehensive care package to patients predisposed to or suffering from lung, pleural or mediastinal cancers.
The CICT combines:
Gustave Roussy's expertise in oncology management and radiotherapy for thoracic cancers
- The expertise of the Marie-Lannelongue Hospital in the surgical management of thoracic cancers
- The expertise of the Paris Saint-Joseph Hospital in the global management of pulmonology
Rapid diagnosis of lung cancer
- a biopsy, if deemed necessary, using the most appropriate technique for each situation: bronchial fibroscopy, transbronchial echo-endoscopy (TBE) or CT-guided biopsy.
- close collaboration with anatomopathology physicians to diagnose cancer as well as tumour phenotype and genotype
- the use of a reactive technical platform, imaging assessments to investigate disease spread and to conduct exploratory pulmonary and cardiovascular investigations prior to surgery or radiotherapy.